BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  KalVista Pharmaceuticals Presents Data Demonstrating KVD900 Achieves Rapid Exposure and Improves Outcomes as Oral On-Demand Treatment of HAE

  KalVista Pharmaceuticals, Inc. today announced data presented at American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

  November 8, 2021

   · 

  4 min read
• Business

  Ra Medical Systems to Report Third Quarter 2021 Financial Results on November 15, 2021

  Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report third quarter 2021 financial results after market close on Monday, November 15.

  November 8, 2021

   · 

  2 min read
• BioCapital

  To Meet the New OSHA Shots or Tests Mandate, GENETWORx Offers Custom Testing Programs for Corporations

  With Early Investment in Reporting and Compliance Software and Capacity Built During the Pandemic, GENETWORx Provides U.S. Businesses Needed Corporate Testing Expertise

  November 8, 2021

   · 

  4 min read
• QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech

  QuantuMDx Group Limited, announces it has secured a £15 million equity investment from Vita Spring IVD Fund, L.P., a Hong Kong-based venture capital firm focused on early and growth stage medical device companies with disruptive technologies and global market potential.

  November 8, 2021

   · 

  5 min read
• Business

  TYME Technologies, Inc. Provides Business Update and Announces Second Fiscal Quarter 2022 Financial and Operating Results

  First patient dosed in Phase II OASIS trial evaluating the potential benefits of oral SM-88 for patients with metastatic HR+/HER2- breast cancer after treatment with a CDK4/6 inhibitor –

  November 8, 2021

   · 

  13 min read
• Biotech Bay

  Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference

  Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer, will present at the Stifel 2021 Virtual Healthcare Conference taking place on November 15-17, 2021.

  November 8, 2021

   · 

  1 min read
• Business

  Editas Medicine Announces Third Quarter 2021 Results and Business Updates

  Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today reported business highlights and financial results for the third quarter of 2021.

  November 8, 2021

   · 

  16 min read
• Genetown

  Talaris Therapeutics to Participate at Three Upcoming Virtual Investor Conferences

  Talaris Therapeutics, Inc. (Nasdaq: TALS), today announced that members of its senior management team will participate at the following investor conferences.

  November 8, 2021

   · 

  1 min read
• Business

  Trevena to Release Third Quarter 2021 Financial Results on November 15th, 2021Company to host conference call on Monday, November 15th, 2021 at 8:00 a.m. ET

  Trevena, Inc. today announced that it will release its financial results for the third quarter ended September 30, 2021, prior to the market open on Monday, November 15, 2021.

  November 8, 2021

   · 

  2 min read
• Biotech Bay

  IGM Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference

  IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021 at 2:00 p.m. EST.

  November 8, 2021

   · 

  1 min read